Experimental Neuro-oncology II
Reelin: A new potential microenvironmental factor contributing to Glioblastoma invasion
Development of CAR-T cells targeting TMEM158 and PTPRZ1 for treatment of Glioblastoma
The EGFR-inhibitor Osimertinib inhibits survival of human glioblastoma cells
Spheroids derived from glioblastoma cell lines as model system for rapid and reproducible evaluation of treatment conditions in preclinical trials
FTY720 (Fingolimod) reduces the colony formation and cell viability of human glioblastoma cells in combination with temozolomide
Does FTY720 increase sensitivity of Temozolomid due to down-regulation of N-Cadherin expression in glioblastoma cells?
Glycation leads to increased invasion of glioblastoma cell lines
Expression behaviour of MTH1 in Ependymomas
Expression study of the MAGUK Proteins DLG4, DLG1, Magi2, Shank1, and Homer1 in glioma
Impact of copy number variation profile on cancer stem cell marker expression in vestibular schwannoma
Glucose levels interfere with the expression of sialyltransferases and sialylation in benign and malignant meningioma cell lines
CAR-T cells against three novel antigens show antitumoral efficacy in ex vivo patient derived glioblastoma organoids